blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2444805

EP2444805 - Detection of mesothelin-/megakaryocyte potentiating factor-related peptides in peritoneal fluid for assessment of the peritoneum and the peritoneal cavity [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  10.05.2013
Database last updated on 14.09.2024
Most recent event   Tooltip10.05.2013Application deemed to be withdrawnpublished on 12.06.2013  [2013/24]
Applicant(s)For all designated states
Fujirebio America, Inc.
2751 Centerville Road, Suite 3206
Wilmington, DE 19808 / US
[2012/17]
Inventor(s)01 / O'Shannessy, Daniel J.
912 Hickory Grove Drive
Limerick PA Pennsylvania 19468 / US
02 / Sardesai, Niranjan Y.
102 Savory Lane
North Wales PA Pennsylvania 19454 / US
03 / Sommers, Elizabeth B.
530 N. Five Points Road
Coatesville PA Pennsylvania 19320 / US
 [2012/17]
Representative(s)Olgemöller, Luitgard Maria
Patentanwältin Lindenstraße 12a
81545 München / DE
[2012/17]
Application number, filing date11183171.521.01.2005
[2012/17]
Priority number, dateUS20040538072P21.01.2004         Original published format: US 538072 P
[2012/17]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2444805
Date:25.04.2012
Language:EN
[2012/17]
Type: A3 Search report 
No.:EP2444805
Date:20.06.2012
Language:EN
[2012/25]
Search report(s)(Supplementary) European search report - dispatched on:EP22.05.2012
ClassificationIPC:G01N33/53
[2012/17]
CPC:
G01N33/57407 (EP,US); G01N33/57488 (EP,US); G01N2800/50 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2012/17]
TitleGerman:Erkennung von Mesothelin-/Megakaryozyten zur Potenzierung von faktorbezogenen Peptiden in peritonealer Flüssigkeit zur Bewertung des Peritoneum und Peritonealhöhle[2012/17]
English:Detection of mesothelin-/megakaryocyte potentiating factor-related peptides in peritoneal fluid for assessment of the peritoneum and the peritoneal cavity[2012/17]
French:Détection de peptides relatifs au facteur de potentialisation des mésothélines-/mégacaryocytes dans le fluide péritonéal à des fins d'évaluation du péritoine et de la cavité péritonéale[2012/17]
Examination procedure21.12.2012Application deemed to be withdrawn, date of legal effect  [2013/24]
28.01.2013Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2013/24]
Parent application(s)   TooltipEP05712014.9  / EP1714151
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20050712014) is  18.09.2009
Fees paidRenewal fee
28.09.2011Renewal fee patent year 03
28.09.2011Renewal fee patent year 04
28.09.2011Renewal fee patent year 05
28.09.2011Renewal fee patent year 06
28.09.2011Renewal fee patent year 07
30.01.2012Renewal fee patent year 08
Penalty fee
Additional fee for renewal fee
31.01.201309   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY]US6083502  (PASTAN IRA [US], et al) [X] 1,12 * column 2 - column 15 * * column 27 - column 28; sequence 2 * [Y] 2-11,13-17;
 [X]WO0050900  (PACIFIC NORTHWEST RESEARCH INS [US], et al) [X] 1-17 * page 1 - page 45; examples 1,2,7,8; claims 1-7,20-26,30,34,37-40,44,50,53; sequences 1, 2, 13 *;
 [Y]WO03021273  (PACIFIC NORTHWEST RES INST [US], et al) [Y] 1-17* claims 1,3,27,36,37 *;
 [XP]WO2004083449  (FUJIREBIO AMERICA INC [US], et al) [XP] 12-17 * claims 1-84; sequences 1-5 *;
 [Y]  - SCHOLLER N ET AL, "Soluble member(s) of the mesothelin /megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC.; US, (19990928), vol. 96, no. 20, ISSN 0027-8424, pages 11531 - 11536, XP002153470 [Y] 1-17 * the whole document *

DOI:   http://dx.doi.org/10.1073/pnas.96.20.11531
by applicantEP0125023
 EP0171496
 EP0173494
 WO8601533
 EP0184187
 WO8702671
 US4816567
 WO9002809
 WO9117271
 WO9201047
 WO9209690
 WO9215679
 WO9218619
 WO9220791
 WO9301288
 US5223409
 US5225539
 US5320956
 US6083502
 WO0050900
    - CHANG ET AL., PROC. NATL. ACAD. SCI. USA, (1996), vol. 93, pages 136 - 140
    - CHANG ET AL., PROC. NATL. ACAD. SCI. USA, (1996), vol. 93, no. 1, pages 136 - 140
    - SCHOLLER ET AL., PROC. NATL. ACAD. SCI. USA, (1999), vol. 96, no. 20, pages 11531 - 11536
    - YAMAGUCHI ET AL., J. BIOL. CHEM., (1994), vol. 269, no. 2, pages 805 - 808
    - SCHOLLER ET AL., PROC. NATL., ACAD. SCI. USA, (1999), vol. 96, no. 20, pages 11531 - 11536
    - KOHLER, MILSTEIN, NATURE, (1975), vol. 256, pages 495 - 497
    - KOZBOR ET AL., IMMUNOL. TODAY, (1983), vol. 4, page 72
    - COLE ET AL., Monoclonal Antibodies and Cancer Therapy, ALAN R. LISS, INC., (1985), pages 77 - 96
    - FUCHS ET AL., BIO/TECHNOLOGY, (1991), vol. 9, pages 1370 - 1372
    - HAY ET AL., HUM. ANTIBOD. HYBRIDOMAS, (1992), vol. 3, pages 81 - 85
    - HUSE ET AL., SCIENCE, (1989), vol. 246, pages 1275 - 1281
    - GRIFFITHS ET AL., EMBO J., (1993), vol. 12, pages 725 - 734
    - BETTER ET AL., SCIENCE, (1988), vol. 240, pages 1041 - 1043
    - LIU ET AL., PROC. NATL. ACAD. SCI. USA, (1987), vol. 84, pages 3439 - 3443
    - LIU ET AL., J. IMMUNOL., (1987), vol. 139, pages 3521 - 3526
    - SUN ET AL., PROC. NATL. ACAD. SCI. USA, (1987), vol. 84, pages 214 - 218
    - NISMMURA, CANCER RES., (1987), vol. 47, pages 999 - 1005
    - WOOD ET AL., NATURE, (1985), vol. 314, pages 446 - 449
    - SHAW ET AL., J. NATL. CANCER INST., (1988), vol. 80, pages 1553 - 1559
    - MORRISON, SCIENCE, (1985), vol. 229, pages 1202 - 1207
    - OI ET AL., BIO/TECHNIQUES, (1986), vol. 4, page 214
    - JONES ET AL., NATURE, (1986), vol. 321, pages 552 - 525
    - VERHOEYAN ET AL., SCIENCE, (1988), vol. 239, page 1534
    - BEIDLER ET AL., J. IMMUNOL., (1988), vol. 141, pages 4053 - 4060
    - SCHOLLER ET AL., PROC. NATL. ACAD. SCI. USA, (1999), vol. 96, no. 12, pages 11531 - 11536
    - HOLLENBAUGH ET AL., J. IMMUNOL. METH., (1995), vol. 188, pages 1 - 7
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.